This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1996.
Company Filing History:
1 out of 834,350 Years Active: 1996
Title: Innovations of Francois D Trooper in Targeted Polymerized Liposome Contrast Agents
Introduction
Francois D Trooper is an innovative inventor based in Oakland, CA (US). He has made significant contributions to the field of medical imaging through his groundbreaking patent on targeted polymerized liposome contrast agents. His work focuses on enhancing imaging techniques to provide better insights into cellular and tissue conditions during disease and pathology.
Latest Patents
Francois D Trooper holds a patent for "Targeted Polymerized Liposome Contrast Agents." This invention involves polymerized liposome particles that are based on lipids with a polymerizable functional group and a metal chelator. These components are designed to attach an imaging enhancement agent and lipids with an active targeting group. The result is a targeted polymerized liposome contrast agent that interacts with receptor targets, allowing for in vivo studies through various imaging modalities such as magnetic resonance, radioactive, x-ray, or optical imaging. This advancement enables the expression of molecules in cells and tissues to be monitored more effectively.
Career Highlights
Throughout his career, Francois D Trooper has demonstrated a commitment to advancing medical imaging technologies. His innovative approach to developing targeted contrast agents has positioned him as a notable figure in the field. With a focus on improving diagnostic capabilities, his work has the potential to significantly impact patient care and treatment outcomes.
Collaborations
Francois has collaborated with esteemed colleagues, including King Chuen Li and Mark David Bednarski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the development of innovative solutions in medical imaging.
Conclusion
Francois D Trooper's contributions to the field of targeted polymerized liposome contrast agents exemplify the importance of innovation in medical imaging. His work not only advances technology but also holds promise for improving diagnostic practices in healthcare.